Search results
Results from the WOW.Com Content Network
A hepatitis C vaccine, a vaccine capable of protecting against the hepatitis C virus (HCV), is not yet available. Although vaccines exist for hepatitis A and hepatitis B, development of an HCV vaccine has presented challenges. [1] No vaccine is currently available, but several vaccines are currently under development. [2] [3]
Chronic hepatitis C is defined as infection with the hepatitis C virus persisting for more than six months based on the presence of its RNA. [18] Chronic infections are typically asymptomatic during the first few decades, [ 18 ] and thus are most commonly discovered following the investigation of elevated liver enzyme levels or during a routine ...
Hepatitis B is spread through blood and body fluids, while hepatitis C is spread only through blood. And while A and B can be prevented through vaccination , says Dr. Menon, there is no current ...
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer ( hepatocellular carcinoma , abbreviated HCC) and lymphomas in humans.
The presence of surface antibody (anti-HBs) indicates an individual with immunity to hepatitis B, whether due to previously resolved infection or due to hepatitis B vaccination. [65] For example, an individual who has never had any exposure to HBV, either by vaccine or by infection, would test negative for the entire serology panel.
Combined hepatitis A and B vaccine, is used to provide protection against hepatitis A and hepatitis B. [3] [7] It is given by injection into muscle.[8]It is used in areas where hepatitis A and B are endemic, for travelers, people with hepatitis C or chronic liver disease, and those at high risk of sexually transmitted diseases.
assessment of vaccine efficacy and safety; consumer perspectives and/or social and community aspects of immunization programs; at least one member must be an expert in this category. No-one who is currently employed by or involved with any employees of vaccine manufacturing companies or who holds a patent for a vaccine can be a member of ACIP.
The main benefit of cell-based vaccines is the ability to rapidly produce vaccine supplies during an impending pandemic. Cell-based antigen production offer a faster and more stable production of vaccines compared to embryonic chicken eggs, which produce 1-2 vaccine doses per chicken egg. [8]